Evolving mucocutaneous eruptions following chemotherapy
Saved in:
Main Authors: | Ailynna Chen, MPH (Author), Ashley P. Patrick, MD (Author), Zakariyah Sharif-Sidi, MD (Author), Vincent Liu, MD (Author), Janet A. Fairley, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reactive infectious mucocutaneous eruption following COVID-19 infection in vaccinated patients
by: Michael Aw, BSc, et al.
Published: (2023) -
Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2
by: C. Yoonhee Ryder, BS, et al.
Published: (2021) -
Clinical and microbiological characteristics of reactive infectious mucocutaneous eruption: A case series of 5 patients
by: Camilla Vassallo, MD, et al.
Published: (2021) -
Recurrent Mycoplasma pneumoniae-associated reactive infectious mucocutaneous eruption responsive to systemic steroids: A case series
by: Hasina Maredia, MD, et al.
Published: (2021) -
Rash from the past: A case of recurrent reactive infectious mucocutaneous eruption triggered by common coronavirus
by: Jeffrey A. Lowell, MD, PhD, et al.
Published: (2024)